1
Postma, M.J., Kappelhoff, B.S., van Hulst, M., Brouwers, J.R.
Veröffentlicht in: Postma , M J , Kappelhoff , B S , van Hulst , M & Brouwers , J R 2012 , ' Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the netherlands ' , Journal of Medical Economics , vol. 15 , no. 5 , pp. 878-886 .;
2012
Veröffentlicht in: Postma , M J , Kappelhoff , B S , van Hulst , M & Brouwers , J R 2012 , ' Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the netherlands ' , Journal of Medical Economics , vol. 15 , no. 5 , pp. 878-886 .;
2012
2
Stevanovic, J., de Jong, L. A., Kappelhoff, B. S., Dvortsin, E. P., Voorhaar, M., Postma, M. J.
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016